Search results for

In an unexpected turnaround, on December 26 2000, the Clinton administration killed a proposal to allow imports of low-priced prescription drugs into the United States. Congress abandoned the controversial plan on the grounds that it would be unsafe and would not achieve its aim of providing the public with cheap drugs. Describing the proposal as severely flawed, Donna E Shalala , secretary of health and human services, echoed the concerns of pharma companies who believed that without sufficient funding and strict regulations, the plan would have had a devastating effect on public safety.

The Andean Pact member states have long been viewed as a backwater in the technology field. But, reports James Nurton, the new Decision 486 should radically improve patent protection and transform that image

January 1 2000, as for many developing countries, was an important date in India’s diary. It marked the end of the country’s five-year transition period and the moment it became subject to the TRIPs agreement. Tabitha Parker spoke to two senior industry figures about the change

The decision of the Court of Appeal in Douglas & Others v Hello Ltd has been heralded as having recognized a right of privacy in English law. Stephen Bate and Lawrence Abramson analyze the decision and its implications

Nearly a decade after the first release of shocking advertising images by Benetton, the German Federal Constitutional Court has now found the ads acceptable. Henning Hartwig examines the landmark decision, which has finally put an extensive discussion to rest

Fact they say is stranger than fiction. In the David v Goliath case that is Trovan v Pfizer this is certainly true. In the story David slays Goliath and is proclaimed king. In the Trovan case, Pfizer´ s Goliath is made of stronger stuff. On January 11, Trovan filed an appeal in the Ninth Circuit Court challenging an earlier ruling which overturned a record $143 million damages award to the company for infringement of its Trovan trade mark.

With TRIPs compliance, legislative reform and a booming technology market, 2000 was a busy year for patent owners in the emerging markets. MIP writers reveal the results of our annual survey and profile some of the interesting stories from the past year

As global trade increases, technology transfer will play a more important role. Walt Bratic and Sanford Warren provide a guide to putting deals together

Membership of the European Union came one year closer for many Eastern European countries last year, but as governments rush through necessary legislation, consumers and companies are being left behind. Tabitha Parker reports

The year 2000 saw important progress regarding both the Community Patent and the European Patent Convention. Neil Jenkins reviews the developments and looks forward to further changes